News Headline Summary
Novartis (NOVN VX) CEO says has proven track record of bringing products
- Has confidence in Serelaxin.
Reaction details (12:14)
- Co. shares move to fresh intra-day highs following these comments in a move higher of 0.48%; trades CHF 57.35 last.
08 Nov 2012 - 12:11
Subscribe Now to
Click here for a 1 week free trial
provides audio news and commentary for over 15,000
professional traders and brokers worldwide. Services include:
Real-time audio coverage from 0630 to 2200 London time plus Asia-Pac 2200 to 1000 London time
Teams of analysts covering equities, fixed income, FX, energy, and metals markets
Real-time scrolling news service with instant analysis
Daily and weekly pre-market research and calendars
Video updates covering near-term key risk events & primary trading themes
One-to-one chat with our expert analysts